Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05470595
Title A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung (LCNEC-ALPINE)
Acronym LCNEC-ALPINE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Technische Universitaet Dresden
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.